EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Peripapillary Epinephrine Injection vs Rectal Indomethacin in Preventing Post-ERCP Pancreatitis: A randomized controlled trial

S. Tokmak, M. F. Cetin, A. Sirin, S. Konur, S. Torun

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S20

DOI: 10.1055/s-0044-1782726 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von S. Tokmak und 4 weiteren Autor:innen. Die Arbeit nennt 2 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Post-ERCP pancreatitis (PEP) is still the most common major complication of ERCP despite technical advancements and meticulous patient selection. The efficacy of the existing techniques is conflicting. We aimed to compare the efficacy of peripapillary epinephrine injection and rectal indomethacin in the prevention of PEP. [ 1 ] [ 2 ]

Methods

Between January 2023 and August 2023, a total of 378 patients were enrolled. We calculated that 189 patients in each group (rectal indomethacin – Group A and peripapillary epinephrine injection – Group B) would suffice based on a previous study by our group (α:0.05, 80% power). Patients with a non-naive papillae, ampulla of Vater cancer, biliary pancreatitis, altered anatomy, pregnancy, and pancreatic diseases such as chronic pancreatitis were excluded. Patients were assigned in a 1:1 simple randomized fashion. The primary outcome was the rate of PEP. Secondary outcomes were the rate of hyperamylasemia and rates of other adverse events Results Demographic characteristics, indications, and procedure-related risk factors were similar between the groups. The overall success rate of selective cannulation was 99.2% in Group A and 99.3% in Group B (p=0.997). PEP occurred in 9 of the 189 (4.8%) patients in Group A and 2 of the 189 (0.5%) patients in Group B. All cases were mild and managed conservatively. The rate of post-procedure 4th-hour hyperamylasemia was significantly higher in Group A (19% vs 5%, p

Zitieren

APA

Tokmak, S., Cetin, M. F., Sirin, A., Konur, S., & Torun, S. (2024). Peripapillary Epinephrine Injection vs Rectal Indomethacin in Preventing Post-ERCP Pancreatitis: A randomized controlled trial. Endoscopy, 56(S 02 S 02), S20. https://doi.org/10.1055/s-0044-1782726

Vancouver

Tokmak S, Cetin MF, Sirin A, Konur S, Torun S. Peripapillary Epinephrine Injection vs Rectal Indomethacin in Preventing Post-ERCP Pancreatitis: A randomized controlled trial. Endoscopy. 2024;56(S 02 S 02):S20. doi:10.1055/s-0044-1782726

BibTeX
@article{Tokmak2024,
  author = {Tokmak, S. and Cetin, M. F. and Sirin, A. and Konur, S. and Torun, S.},
  title = {Peripapillary Epinephrine Injection vs Rectal Indomethacin in Preventing Post-ERCP Pancreatitis: A randomized controlled trial},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S20},
  doi = {10.1055/s-0044-1782726}
}
Kostenlos starten →